MeSH term
Frequency | Condition_Probility | Adult | 17 | 0.0 |
Familial Mediterranean Fever/complications/*genetics | 2 | 40.0 |
Female | 32 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Genotype | 17 | 0.0 |
Heterozygote | 7 | 0.0 |
Humans | 67 | 0.0 |
Jews | 3 | 4.0 |
Male | 30 | 0.0 |
*Mutation | 9 | 0.0 |
Phenotype | 10 | 0.0 |
Proteins/*genetics | 19 | 1.0 |
Amino Acid Sequence | 6 | 0.0 |
Amino Acid Substitution | 4 | 0.0 |
Antigens, CD/*genetics | 2 | 0.0 |
Familial Mediterranean Fever/*genetics | 15 | 68.0 |
Molecular Sequence Data | 7 | 0.0 |
Pedigree | 9 | 0.0 |
Receptors, Tumor Necrosis Factor/*genetics | 2 | 3.0 |
Receptors, Tumor Necrosis Factor, Type I | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 34 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Adolescent | 11 | 0.0 |
DNA Mutational Analysis | 7 | 0.0 |
Follow-Up Studies | 3 | 0.0 |
Japan | 2 | 0.0 |
Mutation, Missense | 6 | 0.0 |
*Point Mutation | 4 | 0.0 |
Child | 13 | 0.0 |
Child, Preschool | 8 | 0.0 |
Infant | 3 | 0.0 |
Mutation | 20 | 0.0 |
Gene Frequency | 5 | 0.0 |
Mutation/*genetics | 4 | 0.0 |
Colchicine/therapeutic use | 2 | 18.0 |
Comparative Study | 5 | 0.0 |
Proteins/genetics | 7 | 0.0 |
Interleukin-1/pharmacology | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 6 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Prognosis | 5 | 0.0 |
Alleles | 4 | 0.0 |
DNA/chemistry/genetics | 2 | 0.0 |
Iraq/ethnology | 2 | 20.0 |
Israel | 5 | 3.0 |
Jews/*genetics | 5 | 3.0 |
Cloning, Molecular | 3 | 0.0 |
Exons | 3 | 0.0 |
Family Health | 2 | 0.0 |
Polymerase Chain Reaction | 9 | 0.0 |
Animals | 3 | 0.0 |
Hela Cells | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 5 | 0.0 |
Transfection | 2 | 0.0 |
*Heterozygote | 4 | 1.0 |
Turkey | 2 | 1.0 |
*Alleles | 2 | 0.0 |
Diagnosis, Differential | 3 | 0.0 |
*Maximal Expiratory Flow-Volume Curves | 3 | 75.0 |
Middle Aged | 7 | 0.0 |
Familial Mediterranean Fever/complications/*genetics/pathology | 2 | 100.0 |
Homozygote | 4 | 0.0 |
Proteins/*genetics/metabolism | 2 | 0.0 |
Amyloidosis/*genetics | 4 | 14.0 |
Cells, Cultured | 3 | 0.0 |
Africa, Northern/ethnology | 2 | 13.0 |
Familial Mediterranean Fever/ethnology/*genetics | 4 | 100.0 |
Arabs/*genetics | 2 | 7.0 |
*Gene Frequency | 2 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Arabs/genetics | 2 | 12.0 |
Armenia/ethnology | 3 | 75.0 |
Jews/genetics | 3 | 3.0 |
Turkey/ethnology | 2 | 6.0 |
Base Sequence | 7 | 0.0 |
DNA Primers | 6 | 0.0 |
*Immunoglobulin D | 2 | 40.0 |
Linkage (Genetics) | 3 | 0.0 |
Recurrence | 2 | 0.0 |
Syndrome | 3 | 0.0 |
Greece/ethnology | 2 | 10.0 |
Middle East/ethnology | 2 | 20.0 |
Exons/genetics | 2 | 0.0 |
Familial Mediterranean Fever/epidemiology/*genetics | 2 | 100.0 |
Microsatellite Repeats | 2 | 0.0 |
Chromosomes, Human, Pair 16/*genetics | 2 | 2.0 |
Transcription, Genetic | 2 | 0.0 |
English Abstract | 3 | 0.0 |
Genetic Markers | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Reproducibility of Results | 3 | 0.0 |
Familial Mediterranean Fever/*diagnosis/*genetics | 2 | 100.0 |
Airway Resistance | 2 | 10.0 |
Maximal Expiratory Flow-Volume Curves | 2 | 40.0 |
Familial Mediterranean Fever/*genetics/metabolism | 3 | 75.0 |
*Forced Expiratory Flow Rates | 2 | 66.0 |
Total Lung Capacity | 2 | 18.0 |
Vital Capacity | 2 | 5.0 |
Serum Amyloid A Protein/*metabolism | 2 | 5.0 |
Prevalence | 2 | 0.0 |
Ethnic Groups/*genetics | 2 | 1.0 |
